Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
N alpha-methyl histamine versus propranolol for migraine prophylaxis
ACTRN12610000126011Phase 3Not yet recruiting
- Sponsor
- Hospital General de Zona 1 IMSS
- Start
- Mar 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of n-alpha-methylhistamine and propranolol in migraine (2 arms), sponsored by Hospital General de Zona 1 IMSS. Primary endpoints: Reduction in rescue medication use, Reduction in headache intensity and 2 more. Planned start Mar 2010; status: not yet recruiting.
02
Drugs
n-alpha-methylhistaminepropranolol
03
Conditions
migraine
Beyond the preview
Go deeper on ACTRN12610000126011.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12610000126011.